Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Stock Charts To Watch: ARWR, AZN, GTHX, IOVA, NKTR, PINS, RUN

Published 06/19/2019, 12:52 AM
Updated 07/09/2023, 06:31 AM
FSLR
-
ARWR
-
NKTR
-
AZN
-
IOVA
-
RUN
-
SNAP
-
GTHX
-
PINS
-

Arrowhead Pharmaceuticals, Inc. (ARWR)

ARWR had a breakout of a 6-day flag on Tuesday with a breakaway gap, popping 1.44, or 5.44%, to 27.89, on 2.1 million shares. It looks like it’s on its way to 31-32. Those are my next targets.

AstraZeneca PLC (AZN)

AZN on positive drug news on Tuesday, popped 97 cents, or 2.43%, to 40.95, on 3.1 million shares. We’ll see if that follows through. Targets are at the gap at 41.50, and then the highs at 43.30.

G1 Therapeutics, Inc. (GTHX)

GTHX popped and had a big breakaway of 4.75, or 24%, to 24.50, on 2.3 million shares. That’s the biggest volume since Dec when it bottomed. To me, Tuesday was a breakout day. It’s headed for 30 and 36.

Iovance Biotherapeutics, Inc. (IOVA)

IOVA continues to push forward, advancing another 45 cents, or 2%, to 22.40, on 2.1 million shares. It’s at the tail end of a multiple wave, so be careful.

Nektar Therapeutics (NKTR)

NKTR is building a nice-little mini base after a long drop. It popped and pulled back, popped and pulled back, and on Tuesday, it popped again, jumping 1.47, or 4.36%, to 35.17, on 942,101 shares traded. I need this stock to get through the double-top at 35.80, and then it can run to 38 3/4 and 40.

Pinterest, Inc (PINS)

PINS exploded after the IPO in April, pulled down sharply, broke out again and retested, and is moving yet again, on Tuesday gaining 95 cents, or 3.4%, to 28.80, on 1.6 million shares. Targeting about 31, and if it gets through that, then 33 3/4-34 going forward.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Sunrun Inc. (RUN)

Sunrun Inc (NASDAQ:RUN) another one of the solar stocks we follow, broke out of an inverse head-and-shoulders, with an up-sloping neckline, but it pointed to lateral resistance first, formed a double top, and popped 1.18, or 6.9%, to 18.27, on 4.1 million shares. It’s headed probably to 20, maybe 21.

Stocks on the long side

Arrowhead Pharmaceuticals, Inc. (ARWR), AstraZeneca PLC (AZN), Beyond Meat, Inc. (BYND), CRISPR Therapeutics AG (CRSP), First Solar, Inc. (NASDAQ:FSLR), G1 Therapeutics, Inc. (GTHX), HUYA Inc. (HUYA), Iovance Biotherapeutics, Inc. (IOVA), Direxion Daily Jr Gld Mnrs Bull 3X ETF (JNUG), Direxion Daily S&P Biotech Bull 3X ETF (LABU), Momo Inc. (MOMO), Nektar Therapeutics (NKTR), Direxion Daily Gold Miners Bull 3X ETF (NUGT), PhaseBio Pharmaceuticals, Inc. (PHAS), Impinj, Inc. (PI), Pinterest, Inc. (PINS), RingCentral, Inc. (RNG), Sunrun Inc. (RUN), SolarEdge Technologies, Inc. (SEDG), VanEck Vectors Semiconductor ETF (SMH), Snap Inc. (NYSE:SNAP), Soliton, Inc. (SOLY), SunPower Corporation (SPWR), Guggenheim Solar ETF (TAN), ViewRay, Inc. (VRAY), Vivint Solar, Inc. (VSLR), Voyager Therapeutics, Inc. (VYGR), Intrexon Corporation (XON), and Zynerba Pharmaceuticals, Inc. (ZYNE).

Watch Video Here

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.